Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Nicolas M Van Mieghem Added: 1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) in addition to optimal heart failure therapy (OHFT) compared to OHFT alone in patients with heart failure and moderate aortic stenosis.Dr Nicolas M Van Mieghem (Erasmus University Medical Center, Rotterdam, NL) joins us onsite at TCT Conference to discuss the findings from TAVR UNLOAD (NCT02661451)… View more
Author(s): Volker Rudolph , Stephan Baldus Added: 1 year ago
ESC Congress 2024 — TEER non-inferior to mitral valve surgery with regard to death, HF rehospitalisation, stroke, reintervention of LVAD at one year.Dr Volker Rudolph (Heart and Diabetes Center NRW, DE) and Prof Stephan Baldus (University Hospital of Köln, DE) joins us in London to discuss the MATTERHORN trial (NCT02371512; University Hospital of Köln).This multicenter, randomized controlled… View more
The Heart Failure Association (HFA) of the ESC has a mission to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research. ) is an independent, non-profit organisation. Its members and decision-makers are busy healthcare professionals who volunteer their time and… View more
Author(s): Marat Fudim Added: 1 year ago
THT Conference 2025 - Findings show catheter ablation of the right greater splanchnic nerve (GSN) in patients with heart failure with preserved ejection fraction (HFpEF) reduced estimated stressed blood volume in patients whether the ablation caused clinical benefits or not. This outcome indicates a confirmation of technical success that correlates with prior single-arm study findings.Dr Marat… View more
Added: 2 months ago Source:  Cardiac Failure Review
The optimal timing for complete revascularisation in patients with ST-segment elevation myocardial infarction (STEMI) and multi-vessel disease who also present with heart failure is a key clinical question. A pre-specified subgroup analysis of the OPTION-STEMI trial suggests that a staged approach may be preferable to immediate complete revascularisation in this high-risk patient group… View more
Author(s): Michelle Kittleson Added: 1 year ago
ESC 2024 - We are joined by Dr Michelle Kittleson (Cedars-Sinai Heart Institute, US) for a concise and insightful summary of the hot-line and late-breaking data that is expected to have an impact on heart failure care.Trials covered in detail include:FINEARTS HFHELIOS-BRESHAPE HF2Recorded remotely from Los Angeles, 2024.Editors: Jordan Rance and Mirjam Boros.Videographers: Mike Knight, Dan Brent,… View more
Job title: Heart Failure Cardiologist
Dr Novi Yanti Sari is a heart failure cardiologist from Indonesia. She graduated from the National Cardiovascular Center Harapan Kita–Faculty of Medicine, University of Indonesia, then pursued a fellowship in advanced HF at the National University Heart Centre Singapore. She pioneered the first heart failure and cardio-oncology pr gram in South Sumatra, Indonesia, and now leads both programs at… View more
Research Area(s) / Expertise: Job title: Professor
Prof Christiane E. Angermann is trained in Medicine/Cardiology in Munich. At the Munich Univ. Hospital, she established a Multidisciplinary Program for Advanced Heart Failure (HF)/HTX. In 2001, she became Professor of Medicine/Cardiology at Würzburg University, heading the Cardiology Division, Department of Medicine II. She is one of the 5 founders of the Comprehensive Heart Failure Center… View more